SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001193125-21-119305
Filing Date
2021-04-16
Accepted
2021-04-16 16:01:52
Documents
1

Document Format Files

Seq Description Document Type Size
1 POS AM d166758dposam.htm POS AM 18780
  Complete submission text file 0001193125-21-119305.txt   19866
Mailing Address 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 415-365-5600
FIVE PRIME THERAPEUTICS, INC. (Filer) CIK: 0001175505 (see all company filings)

IRS No.: 260038620 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-228206 | Film No.: 21831448
SIC: 2834 Pharmaceutical Preparations